We are live on ! Find out more
KP

Kiltearn Partners Portfolio holdings

AUM $372M
1-Year Est. Return 18.16%
This Fund
S&P 500
This Quarter Est. Return
+2.69%
1 Year Est. Return
+18.16%
3 Year Est. Return
+34.48%
5 Year Est. Return
+43.43%
10 Year Est. Return
+168.94%
AUM
$3.42B
AUM Growth
+$311M
Cap. Flow
+$215M
Cap. Flow %
6.28%
Top 10 Hldgs %
66.48%
Holding
24
New
2
Increased
13
Reduced
7
Closed
2

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$116M
2
GE icon
GE Aerospace
GE
+$107M
3
UNFI icon
United Natural Foods
UNFI
+$64.5M
4
SLB icon
SLB Ltd
SLB
+$51.3M
5
VIAB
Viacom Inc. Class B
VIAB
+$42.9M

Top Sells

Rank Stock Value
1
KT icon
KT
KT
+$127M
2
BWA icon
BorgWarner
BWA
+$60.1M
3
PII icon
Polaris
PII
+$40M
4
L icon
Loews
L
+$22.7M
5
STT icon
State Street
STT
+$15.8M

Sector Composition

Rank Sector Weight
1 Financials 51.7%
2 Consumer Discretionary 16.21%
3 Healthcare 11.19%
4 Technology 5.79%
5 Energy 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
C icon
1
Citigroup
C
$216B
$322M 9.41%
4,424,311
-114,400
-3% -$7.81M
GS icon
2
Goldman Sachs
GS
$295B
$320M 9.34%
1,347,637
+8,100
+0.6% +$1.83M
BEN icon
3
Franklin Resources
BEN
$16.9B
$274M 8.01%
6,157,600
+38,900
+0.6% +$1.7M
AXP icon
4
American Express
AXP
$227B
$224M 6.56%
2,480,235
-39,465
-2% -$3.39M
MCK icon
5
McKesson
MCK
$105B
$215M 6.28%
1,399,532
+157,400
+13% +$24.6M
MS icon
6
Morgan Stanley
MS
$325B
$209M 6.11%
4,341,197
-73,400
-2% -$3.4M
IVZ icon
7
Invesco
IVZ
$12.4B
$203M 5.94%
5,803,410
+37,900
+0.7% +$1.29M
HOG icon
8
Harley-Davidson
HOG
$2.6B
$174M 5.08%
3,606,600
+847,300
+31% +$41.2M
CVS icon
9
CVS Health
CVS
$136B
$168M 4.91%
2,065,200
+1,461,400
+242% +$116M
Y
10
DELISTED
Alleghany Corp
Y
$165M 4.82%
297,880
+39,300
+15% +$22.9M
UNFI icon
11
United Natural Foods
UNFI
$3.07B
$157M 4.58%
3,768,839
+1,733,394
+85% +$64.5M
PII icon
12
Polaris
PII
$3.8B
$140M 4.08%
1,334,076
-421,800
-24% -$40M
HP icon
13
Helmerich & Payne
HP
$3.35B
$131M 3.83%
2,516,102
+226,800
+10% +$11.2M
ARW icon
14
Arrow Electronics
ARW
$10.5B
$128M 3.75%
1,597,400
+10,800
+0.7% +$853K
GE icon
15
GE Aerospace
GE
$368B
$102M 2.98%
+880,971
New +$107M
BWA icon
16
BorgWarner
BWA
$12.7B
$95.1M 2.78%
2,109,157
-1,472,028
-41% -$60.1M
AN icon
17
AutoNation
AN
$7.74B
$87.8M 2.57%
1,849,874
-189,126
-9% -$8.19M
VIAB
18
DELISTED
Viacom Inc. Class B
VIAB
$72.6M 2.12%
2,608,000
+1,391,300
+114% +$42.9M
GLW icon
19
Corning
GLW
$107B
$69.7M 2.04%
2,330,779
+14,800
+0.6% +$438K
WSM icon
20
Williams-Sonoma
WSM
$27.4B
$58.1M 1.7%
2,330,094
+728,200
+45% +$16.9M
SLB icon
21
SLB Ltd
SLB
$73.3B
$54.1M 1.58%
+775,500
New +$51.3M
STT icon
22
State Street
STT
$49B
$51.4M 1.5%
537,895
-169,919
-24% -$15.8M
KT icon
23
KT
KT
$8.79B
-7,659,546
Closed -$127M
L icon
24
Loews
L
$24.6B
-485,327
Closed -$22.7M

Similar funds

Kiltearn Partners's Q3 2017 Portfolio in Review

As of Q3 2017, Kiltearn Partners held 24 positions worth $3.42B, up 10% from $3.11B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Kiltearn Partners deployed $215M of net new capital in Q3 2017, opening 2 new positions and adding to 13 existing holdings. Its largest new stake was GE Aerospace: 880,971 shares worth $102M.

By sector, the portfolio is most concentrated in Financials at 52% of assets, down from 56% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was BorgWarner, an estimated $60.1M trimmed.

  • Kiltearn Partners's largest Q3 2017 buy was GE Aerospace: 880,971 shares worth $102M.
  • Kiltearn Partners added most to CVS Health in Q3 2017, an estimated $116M increase.
  • Kiltearn Partners's biggest Q3 2017 reduction was BorgWarner, cutting an estimated $60.1M.
  • Kiltearn Partners fully exited KT in Q3 2017, selling an estimated $127M.
  • Kiltearn Partners's ten largest holdings make up 66% of its $3.42B portfolio in Q3 2017.
  • Kiltearn Partners opened 2 new positions and closed 2 in Q3 2017.
  • Kiltearn Partners's portfolio value rose 10% quarter-over-quarter to $3.42B.

Based on Kiltearn Partners's 13F filing for Q3 2017, filed 13 Nov 2017.